Article
Varied histomorphology and clinical outcomes of FGFR3-TACC3 fusion gliomas.
Neurosurgical focus - 1 Dec 2022
McDonald Malcolm F, Athukuri Prazwal, Anand Adrish, Gopakumar Sricharan, Jalali Ali, Patel Akash J, Rao Ganesh, Goodman J Clay, Lu Hsiang-Chih, Mandel Jacob J
Abstract excerpt
Targeted therapies for driver gene fusions in cancers have yielded substantial improvements in care. Here, the authors outline a case series of 6 patients with FGFR3-TACC3 fusion in primary brain tumors ranging from polymorphous low-grade neuroepithelial tumor of the young to papillary glioneuronal tumors and glioblastoma (GBM). Previous studies indicated the FGFR3-TACC3 fusion provides survival benefit to GBM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
